Evidence map›Paper›PMID 18599872›Full record

ArticleCirculation research2008

Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity.

Zhibo Lu, Jun-ichi Abe, Jack Taunton, Yan Lu, Tetsuro Shishido, Carolyn McClain, Chen Yan, Sheng Ping Xu, Thomas M Spangenberg, Haodong Xu

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. RNAi-mediated p38δ silencing mitigates anthracycline cardiotoxicity in female mice.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  2. Review
  3. Article
  4. Role of p90RSK in Kidney and Other Diseases.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhibo LuDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Jun-ichi Abe
Jack Taunton
Yan Lu
Tetsuro Shishido
Carolyn McClain
Chen Yan
Sheng Ping Xu
Thomas M Spangenberg
Haodong Xu
University of California, San Francisco · US

Funding

Vascular Inflammation and AtherosclerosisP01HL077789 · NHLBI · UNIVERSITY OF ROCHESTER · PI FUJIWARA, KEIGI · 2005 to 2009
$10.1M
Kinases-mediated SUMOylation in Diabetic CardiomyopathyR01HL088637 · NHLBI · UNIVERSITY OF ROCHESTER · PI ABE, JUN-ICHI, YANG, JAY · 2008 to 2011
$2.0M
Big MAP Kinase 1-Cx 43 Signaling in Ischemia InjuryR01GM071485 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI YANG, JAY · 2005 to 2008
$1.5M
Highly Selective, Irreversible Protein Kinase InhibitorsR01GM071434 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TAUNTON, JACK · 2005 to 2008
$1.1M
Role of Modulation of Ito,f by Kinases in Cardiac DysrhythmiasK08HL088127 · NHLBI · UNIVERSITY OF ROCHESTER · PI XU, HAODONG · 2007 to 2011
$621k
NHLBI NIH HHS HL-077789NHLBI NIH HHS K08 HL088127NHLBI NIH HHS P01 HL077789NHLBI NIH HHS R01 HL088637NIGMS NIH HHS GM071434-03NIGMS NIH HHS GM-071485NIGMS NIH HHS R01 GM071434NIGMS NIH HHS R01 GM071485
6 · The paper itself

Abstract

p90 ribosomal S6 kinase (p90RSK) is activated in cardiomyopathies caused by conditions such as ischemia/reperfusion injury and diabetes mellitus in which prolongation of cardiac repolarization and frequent arrhythmias are common. Molecular mechanisms underlying the electric remodeling in cardiac diseases are largely unknown. In the present study, we determined the role of p90RSK activation in the modulation of voltage-gated K+ channel activity determining cardiac repolarization. Mice with increased cardiac p90RSK activity due to transgenic expression of p90RSK (p90RSK-Tg) had prolongation of QT intervals and of ventricular myocyte action potential durations. Fast transient outward K+ current (I(to,f)), slow delayed outward K+ current (I(K,slow)), and steady-state K+ current (I(SS)) were significantly decreased in p90RSK-Tg mouse ventricular myocytes. mRNA levels of Kv4.3, Kv4.2, Kv1.5, Kv2.1, and KChIP2 from ventricles between p90RSK-Tg and nontransgenic littermate control mice were similar, as assessed by quantitative reverse transcriptase-polymerase chain reaction, indicating that p90RSK regulates voltage-gated K+ channels through posttranslational modification. Kv4.3- and Kv1.5- rather than Kv4.2- and Kv2.1-encoded channels in HEK 293 cells were inhibited by p90RSK. In vitro phosphorylation analysis showed that Kv4.3 was phosphorylated by p90RSK at 2 conserved sites, Ser516 and Ser550. p90RSK expression significantly inhibited Kv4.3- and Kv4.3 and KChIP2-encoded channel activities in HEK 293 cells, whereas p90RSK's effects were blocked by amino acid mutation(s) at phosphorylation site(s) in Kv4.3. Hydrogen peroxide, a mediator of induced cardiac p90RSK activation in ischemia/reperfusion injury and diabetes mellitus, had effects similar to those of p90RSK on Kv4.3- or Kv4.3- and KChIP2-encoded channels. Fluoromethylketone, a specific p90RSK inhibitor, abolished hydrogen peroxide effects. These findings indicate that p90RSK activation is critical for reactive oxygen species-mediated inhibition of voltage-gated K+ channel activity and leads to prolongation of cardiac repolarization.

Indexed as

Action PotentialsAnimalsEnzyme ActivationHeartHeart VentriclesHydrogen PeroxideLong QT SyndromeMembrane PotentialsMiceMice, TransgenicMyocytes, CardiacPotassium Channels, Voltage-GatedReactive Oxygen SpeciesRibosomal Protein S6 Kinases, 90-kDaHydrogen PeroxidePotassium Channels, Voltage-GatedReactive Oxygen SpeciesRibosomal Protein S6 Kinases, 90-kDa

Identifiers

PMID18599872
PMCPMC2631445
OpenAlexW2138678779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.